Pages that link to "Item:Q3076045"
From MaRDI portal
The following pages link to Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials (Q3076045):
Displaying 11 items.
- Sensitivity analysis for evaluating principal surrogate endpoints relaxing the equal early clinical risk assumption (Q2170431) (← links)
- An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference (Q2827172) (← links)
- Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials (Q2846433) (← links)
- Surrogate Measures and Consistent Surrogates (Q2861938) (← links)
- Comparing Biomarkers as Principal Surrogate Endpoints (Q2893405) (← links)
- Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling (Q3119801) (← links)
- A Bayesian Approach to Improved Estimation of Causal Effect Predictiveness for a Principal Surrogate Endpoint (Q4649074) (← links)
- Bayesian Inference for the Causal Effect of Mediation (Q4911924) (← links)
- A Multiple Imputation Approach for the Evaluation of Surrogate Markers in the Principal Stratification Causal Inference Framework (Q4984852) (← links)
- A unified evaluation of differential vaccine efficacy (Q6047741) (← links)
- Surrogate marker assessment using mediation and instrumental variable analyses in a case-cohort design (Q6104106) (← links)
